Beck Mack & Oliver’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-284,245
| Closed | -$245K | – | 221 |
|
|
2019
Q4 | $245K | Sell |
284,245
-9,984
| -3% | -$7.67K | 0.01% | 184 |
|
|
2019
Q3 | $165K | Sell |
294,229
-300
| -0.1% | -$161 | 0.01% | 199 |
|
|
2019
Q2 | $153K | Buy |
+294,529
| New | +$147K | 0.01% | 209 |
|
|
2018
Q4 | – | Sell |
-329,129
| Closed | -$174K | – | 237 |
|
|
2018
Q3 | $174K | Sell |
329,129
-100
| -0% | -$54 | 0.01% | 219 |
|
|
2018
Q2 | $165K | Sell |
329,229
-4,030
| -1% | -$1.88K | 0.01% | 219 |
|
|
2018
Q1 | $141K | Sell |
333,259
-126,500
| -28% | -$50.9K | ﹤0.01% | 225 |
|
|
2017
Q4 | $175K | Sell |
459,759
-4,716
| -1% | -$1.79K | 0.01% | 225 |
|
|
2017
Q3 | $167K | Sell |
464,475
-75
| -0% | -$28 | 0.01% | 227 |
|
|
2017
Q2 | $177K | Hold |
464,550
| – | – | 0.01% | 227 |
|
|
2017
Q1 | $209K | Hold |
464,550
| – | – | 0.01% | 214 |
|
|
2016
Q4 | $177K | Sell |
464,550
-4,000
| -0.9% | -$1.35K | 0.01% | 217 |
|
|
2016
Q3 | $127K | Sell |
468,550
-100
| -0% | -$25 | ﹤0.01% | 222 |
|
|
2016
Q2 | $112K | Sell |
468,650
-250
| -0.1% | -$43 | ﹤0.01% | 263 |
|
|
2016
Q1 | $53K | Sell |
468,900
-300
| -0.1% | -$33 | ﹤0.01% | 269 |
|
|
2015
Q4 | $53K | Sell |
469,200
-6,850
| -1% | -$967 | ﹤0.01% | 280 |
|
|
2015
Q3 | $91K | Sell |
476,050
-50
| -0% | -$17 | ﹤0.01% | 307 |
|
|
2015
Q2 | $333K | Sell |
476,100
-36,312
| -7% | -$25.1K | 0.01% | 264 |
|
|
2015
Q1 | $347K | Sell |
512,412
-6,050
| -1% | -$4.23K | 0.01% | 266 |
|
|
2014
Q4 | $410K | Sell |
518,462
-938
| -0.2% | -$641 | 0.01% | 249 |
|
|
2014
Q3 | $242K | Sell |
519,400
-13,400
| -3% | -$6.5K | 0.01% | 318 |
|
|
2014
Q2 | $266K | Sell |
532,800
-12,100
| -2% | -$5.85K | 0.01% | 310 |
|
|
2014
Q1 | $169K | Sell |
544,900
-600
| -0.1% | -$223 | ﹤0.01% | 340 |
|
|
2013
Q4 | $185K | Sell |
545,500
-171,600
| -24% | -$207K | ﹤0.01% | 346 |
|
|
2013
Q3 | $1.45M | Sell |
717,100
-10,250
| -1% | -$19.5K | 0.04% | 149 |
|
|
2013
Q2 | $1.38M | Buy |
+727,350
| New | +$1.28M | 0.04% | 149 |
|
Beck Mack & Oliver's GCVRZ Position: Q1 2020 in Review
Beck Mack & Oliver sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 284,245 shares — an estimated $245K sold.
Beck Mack & Oliver first reported a position in GCVRZ in Q2 2013 and held it in 25 quarters. The position peaked at $1.45M in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Beck Mack & Oliver reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Beck Mack & Oliver sold 284,245 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $245K.
- Beck Mack & Oliver first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 25 quarters.
- Beck Mack & Oliver's Sanofi Contingent Value Rights position peaked at $1.45M in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Beck Mack & Oliver's 13F filing for Q1 2020, filed 5 May 2020.